Back

The influence of medication costs on secondary cardiovascular prevention decisions: two discrete choice experiments among patients and prescribers

30 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Secondary prevention (2) Secondary Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Elbrich Marieke Wempe

(Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Low molecular weight heparin for AMI with frailty: short-Term outcomes after early PCI
Professor K. Chen (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
COVID-19 vaccination confers long-term cardioprotection against post-COVID cardiovascular disease: >5-year evidence from causal mediation and target trial emulation
Mr B. Seboka (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
The German lipoprotein apheresis registry - summary of the thirteenth annual report
Doctor A. Vogt (Munich, DE)
Abstract Slides Video
Presentation thumbnail
The newest pillar is the most fragile: SGLT2 inhibitors show the lowest 12-month ongoing use among guideline-directed CAD medications in a 15-country European survey
Mr L. Kieviet (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Prevalence and characteristics of low-dose acetylsalicylic acid intake in the German population: insights from the German National Cohort (NAKO)
Professor J. Neumann (Hamburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary prevention (2)

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Secondary prevention of coronary artery disease: a retrospective observational analysis of italian healthcare administrative data
7 April 2022
thumbnail
Congress Presentation
Patient preferences for heart failure medications: a discrete choice experiment
29 August 2026
thumbnail
Congress Presentation
Cost-effectiveness of direct oral anticoagulants for cancer-associated venous thromboembolism
3 September 2019
thumbnail
Congress Presentation
Digitally supported shared decision-making for exercise prescription in the secondary prevention of cardiovascular disease
3 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources